A review of 25 years of National Institute of Health and Care Excellence decision making

被引：0
作者：
Zhang, Xin [1 ]
Tikhonovsky, Natalie [1 ]
Ramagopalan, Sreeram, V [1 ,2 ]
机构：
[1] Lane Clark & Peacock LLP, London W1U 1DQ, England
[2] Kings Coll London, Ctr Pharmaceut Med Res, London SE1 9NH, England
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2024年 / 13卷 / 09期
关键词：
access; decisions; HTA; NICE; reimbursement;
D O I：
10.57264/cer-2024-0063
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 6 条
  • [1] Jenei K, 2023, LANCET ONCOL, V24, P624, DOI [10.1016/S1470-2045(23)00175-4, 10.1016/s1470-2045(23)00175-4]
  • [2] Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop
    Latimer, Nicholas R.
    Pollard, Daniel
    Towse, Adrian
    Henshall, Chris
    Sansom, Lloyd
    Ward, Robyn L.
    Bruce, Andrew
    Deakin, Carla
    [J]. BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [3] Turning CMS into a Health Technology Assessment Organization
    Neumann, Peter J.
    Tunis, Sean R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (08) : 682 - 684
  • [4] NICE, 2024, National Institute for Health and Care Excellence
  • [5] OHE, 2020, NICEOPTIMIZEDDECISIO
  • [6] The Role of Indication-Based Pricing in Future Pricing and Reimbursement Policies: A Systematic Review
    Preckler, Victor
    Espin, Jaime
    [J]. VALUE IN HEALTH, 2022, 25 (04) : 666 - 675
1